Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Amgen Inc. sell Bank of America Co.

Start price
€293.05
05.03.25 / 50%
Target price
€272.83
05.03.26
Performance (%)
-4.95%
Price
€271.40
18:30
Summary
This prediction is currently active. With a performance of -4.95%, the SELL prediction for Amgen Inc. by Bank_of_America_Co_ is down slightly. Dividends of €7.14 are taken into consideration when calculating the performance. This prediction currently runs until 05.03.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Amgen Inc. -4.430% -4.430%
iShares Core DAX® 0.734% 1.458%
iShares Nasdaq 100 -2.686% -0.146%
iShares Nikkei 225® -2.261% -2.729%
iShares S&P 500 -1.346% 0.467%

Comments by Bank_of_America_Co_ for this prediction

In the thread Amgen Inc. diskutieren
Prediction Sell
Perf. (%) -4.95%
Target price 272.832
Change
Ends at 05.03.26

Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Bank of America Co. from $275.00 to $294.00. They now have an "underperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat

Stopped prediction by Bank_of_America_Co_ for Amgen Inc.

Amgen Inc.

Start price
Target price
Perf. (%)
€231.00
26.09.25
€233.10
26.09.26
18.52%
18:30

Amgen Inc.

Start price
Target price
Perf. (%)
€261.75
23.07.25
€222.32
23.07.26
5.51%
18:30

Amgen Inc.

Start price
Target price
Perf. (%)
€297.00
06.02.25
€265.38
06.02.26
-5.45%
18:30